Insider · CIK 0001688865

Alenson Carman

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001688865

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-23	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+140K sh	—	—	140,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−16.1K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+16.1K sh	—	—	16,083
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+90.5K sh	—	—	90,498
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−90.5K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+6,254 sh	—	—	6,254
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−6,254 sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+90.5K sh	—	—	90,498
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−90.5K sh	—	—	0
2025-02-27	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+90.5K sh	—	—	90,500
2024-02-21	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+90.5K sh	—	—	90,498
2023-04-18	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+6,254 sh	—	—	6,254
2023-03-31	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	See Remarks	AAward	+90.5K sh	—	—	90,498
2021-06-21	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+1,777 sh	$51.51	+$91.5K	1,777
2021-06-21	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−1,777 sh	$61.61	−$109K	0
2021-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−1,777 sh	—	—	3,555
2021-04-16	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−1,118 sh	$55.89	−$62.5K	0
2021-04-15	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−991 sh	$54.00	−$53.5K	1,118
2021-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−692 sh	—	—	691
2021-02-22	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Principal Accounting Officer	FTax Payment	−199 sh	—	—	1,795
2021-02-22	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+692 sh	—	—	1,994
2021-02-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+790 sh	—	—	1,863
2021-02-16	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Principal Accounting Officer	FTax Payment	−561 sh	—	—	1,302
2021-02-16	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−790 sh	—	—	0
2021-02-14	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+889 sh	—	—	1,073
2021-02-14	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−889 sh	—	—	1,777
2021-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Principal Accounting Officer	AAward	+2,961 sh	—	—	2,961
2021-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+5,922 sh	—	—	5,922
2020-10-15	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+5,000 sh	—	—	5,000
2020-09-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−250 sh	$39.93	−$9,982.5	184
2020-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−345 sh	$47.30	−$16.3K	184
2020-02-26	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−472 sh	$47.12	−$22.2K	184
2020-02-24	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Principal Accounting Officer	FTax Payment	−219 sh	$48.66	−$10.7K	656
2020-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−691 sh	—	—	1,383
2020-02-22	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+691 sh	—	—	875
2020-02-20	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−2,427 sh	$53.37	−$130K	184
2020-02-18	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Principal Accounting Officer	FTax Payment	−1,163 sh	$52.01	−$60.5K	2,611
2020-02-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+790 sh	—	—	974
2020-02-16	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−790 sh	—	—	790
2020-02-16	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,800 sh	—	—	0
2020-02-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,800 sh	—	—	3,774
2020-02-14	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitA Award	Principal Accounting Officer	AAward	+4,800 sh	—	—	4,800
2020-02-14	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Principal Accounting Officer	AAward	+5,332 sh	—	—	5,332
2020-02-14	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+2,666 sh	—	—	2,666
2019-12-26	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−2,950 sh	$50.09	−$148K	184
2019-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Principal Accounting Officer	AAward	+8,295 sh	—	—	8,295
2019-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+2,074 sh	—	—	2,074
2019-02-21	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−3,300 sh	—	—	0
2019-02-21	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Principal Accounting Officer	FTax Payment	−1,016 sh	$56.33	−$57.2K	2,796
2019-02-21	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+3,300 sh	—	—	3,812

Recent filings

Accepted (ET)
Feb 244
Alenson Carman0001628280-26-011181
SEC(opens sec.gov)
Aug 54
Alenson Carman0001894562-25-000042
SEC(opens sec.gov)
Mar 34
Alenson Carman0001894562-25-000012
SEC(opens sec.gov)
Feb 234
Alenson Carman0001894562-24-000010
SEC(opens sec.gov)
Apr 204
Alenson Carman0001894562-23-000010
SEC(opens sec.gov)
Apr 44
Alenson Carman0001894562-23-000001
SEC(opens sec.gov)
Jun 234
Alenson Carman0001439222-21-000060
SEC(opens sec.gov)
Apr 204
Alenson Carman0001439222-21-000035
SEC(opens sec.gov)
Apr 164
Alenson Carman0001439222-21-000034
SEC(opens sec.gov)
Feb 244
Alenson Carman0001439222-21-000021
SEC(opens sec.gov)

Companies

Address

C/O PRIME MEDICINE, INC. 60 FIRST STREET

CAMBRIDGE, MA, 02141